Galapagos N.V. chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 7.70
Dividend & YieldN/A£ (N/A)
Beta 0.29
Market capitalization N/A
Operating cash flow -504.44M
ESG Scores unknown

Company description

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fibrosis. In addition, its other pipeline products include GLPG2737, a cystic fibrosis transmembrane conductance regulator that is in Phase 2 clinical trials to treat patients with autosomal dominant polycystic kidney disease; and GLPG0555, a JAK1 inhibitor, which is in Phase 1b for treatment of patients with osteoarthritis. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Sector: - Industry:

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -133.32M 2.8B -207.79M -453.72M
Total Cashflows From Investing Activities -15.91M -3.76B 757.29M 541.24M
Net Borrowings -5k -5.09M -6.25M -7.19M
Total Cash From Financing Activities 287.88M 1.34B 22.04M -3.88M
Change To Operating Activities 20M 79.94M 31.16M -35.35M
Issuance Of Stock 303.85M 1.35B 28.29M 3.31M
Net Income -29.26M 149.84M -305.44M -103.23M
Change In Cash 139.59M 570.82M 281.45M 90.3M
Effect Of Exchange Rate 10.09M -9.97M -70.54M 56.76M
Total Cash From Operating Activities -142.47M 3.21B -427.34M -503.83M
Depreciation 4.4M 11.12M 14.84M 16.24M
Change To Account Receivables -76k -67.26M -177.16M 79.86M
Other Cashflows From Financing Activities -15.96M -4.45M
Change To Netincome 15.1M 229.42M 213.3M 8.48M
Capital Expenditures -10.39M -22.39M -42.52M -54.2M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 188.83M
Income Before Tax -29.21M 148.52M -309.77M -123M
Net Income -29.26M 149.84M -305.44M -103.23M
Selling General Administrative 39.78M 96.96M 185.22M 201.54M
Gross Profit -5.03M 414.81M -45.61M -8.49M
Ebit -44.81M 368.75M -178.63M -156.28M
Operating Income -44.81M 368.75M -178.63M -156.28M
Interest Expense -780k -1.27M -9.39M -11.66M
Income Tax Expense 50k -165k 1.23M 2.42M
Total Revenue 317.85M 834.9M 478.05M 484.85M
Cost Of Revenue 322.88M 420.09M 523.67M 493.34M
Total Other Income ExpenseNet 15.6M -220.22M -131.14M 33.28M
Net Income From Continuing Ops -29.26M 148.69M -311M -125.42M
Net Income Applicable To Common Shares -29.26M 149.84M -305.44M -103.23M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 225.25M 3.19B 3.05B 2.55B
Total Stockholder Equity 1.21B 2.88B 2.67B 2.64B
Other Current Liabilities 150.98M 422.53M 456.49M 421.85M
Total Assets 1.44B 6.07B 5.72B 5.19B
Common Stock 294.6M 349.79M 353.82M 354.58M
Other Current Assets 4.1M 4.44M 33.91M 9.3M
Retained Earnings -297.78M -109.22M -334.7M -367.2M
Treasury Stock -60.35M -68.49M -76.6M -74.41M
Cash 1.29B 1.86B 2.14B 2.23B
Total Current Liabilities 219.91M 571.79M 635.27M 566.47M
Other Stockholder Equity -60.35M -68.49M -76.6M -74.41M
Property, Plant, and Equipment 23.14M 66.05M 103.38M 137.51M
Total Current Assets 1.33B 5.87B 5.37B 4.86B
Net Tangible Assets 1.21B 2.87B 2.62B 2.6B
Net Receivables 33.53M 80.11M 173.4M 128.6M
Accounts Payable 68.04M 142.51M 171.32M 134.3M


Insider Transactions

Here are the insider transactions of stock shares related to Galapagos N.V.:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Galapagos N.V.. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Galapagos N.V.

Here is the result of two systematic investment strategies applied to Galapagos N.V.. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Galapagos N.V.

The following chart shows the equity curve of the two systematic investment strategies applied to Galapagos N.V.:

Galapagos N.V. automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0% on the backtest period.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

0.0 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Galapagos N.V.

This is the result of two momentum investment strategies applied to Galapagos N.V.. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Galapagos N.V.

The following chart shows all the entries opened by the momentum investment system on Galapagos N.V.:

Galapagos N.V. momentum entries
  • The first momentum investment strategy would give 6.89% of return on Galapagos N.V.. That represents 18.78£ of latent gain with 272.52£ of employed capital.
  • The second momentum investment strategy would give 0% of return on Galapagos N.V.. That represents 0.0£ of latent gain with 0.0£ of employed capital.
Performance at glance (1Q Momentum)

Performance

6.89 %

Latent gain

18.78 £

Invested capital

272.52 £

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Momentum equity curve on Galapagos N.V.

The following chart shows the equity curve of the two momentum strategies applied to Galapagos N.V.:

Galapagos N.V. momentum equity

Note: the dividends potentially given by Galapagos N.V. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Galapagos N.V.

The following chart shows the employed capital evolution of the two momentum strategies on Galapagos N.V. since the beginning:

Galapagos N.V.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on Galapagos N.V.

Buy the dip entry openings on Galapagos N.V.

Galapagos N.V.

The performance achieved by the robo-advisor on Galapagos N.V. is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows Galapagos N.V. stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Galapagos N.V., and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Equity curve of the strategy applied to Galapagos N.V.

The following chart shows the result of the investment strategy applied to Galapagos N.V.:

Galapagos N.V.

Note: the dividends potentially given by Galapagos N.V. are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Galapagos N.V.

The following chart shows the employed capital evolution since the beginning of the investment strategy on Galapagos N.V.:

Galapagos N.V.

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Galapagos N.V.

In this section, I will compare the three previous investment strategies applied to Galapagos N.V..

Equity curve comparison on Galapagos N.V.

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Galapagos N.V. investment strategy comparison

Employed capital comparison on Galapagos N.V.

Galapagos N.V. investment comparison

Performance comparison on Galapagos N.V.

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0% 0.0£ 0.0£ 0.0%
Momentum 1 quarter 6.89% 18.78£ 272.52£ 172.25%
Momentum 2 quarters 0% 0.0£ 0.0£ -0.0%
Non-directional 0% 0.0£ 0.0£ -0.0%
Annualized return comparison

Automatic investment

0.0 %

Momentum 1Q

-0.0 %

Momentum 2Q

-0.0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Galapagos N.V.:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Galapagos N.V. and the other stocks. There may be false positives or some missing correlated stocks. If the price of Galapagos N.V. does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Galapagos N.V.
Country Belgium
City Mechelen
Address Generaal De Wittelaan L11 A3
Phone 32 1 534 29 00
Website www.glpg.com
FullTime employees 1344
Industry
Sector
Exchange XLON
Ticker 0JXZ.XLON
Market www.londonstockexchange.com

Galapagos N.V. ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown